+1 (202) 780-3397Brief Report - Archives of General Internal Medicine (2023) Volume 7, Issue 4
Brief review of miRNAs as new and natural biomarkers in the treatment of type 2 diabetes mellitus
The prevalence of type-2 diabetes as a progressive metabolic disorder is rapidly increasing worldwide. Diagnosing this disease in the early stages (pre-diabetes) plays an important role in reducing deaths related to this disease. Studies have shown that micro RNAs play an important role in the pathogenesis of type-2 diabetes. Due to the stability of these regulatory molecules in body fluids and the availability of sensitive technology for their measurement, they can be used as genetic biomarkers in the early diagnosis of type-2 diabetes. We made a new diagnosis of disease
Author(s): Ali Salehi